Steven Chan insider trades

Open-market stock purchases and sales by Steven Chan, Chief Financial Officer at Attovia Therapeutics, Inc, from SEC Form 4 filings since Feb 2, 2016.

Recent trades

DateStockTradeValue
Aug 4, 2026ATTO Attovia Therapeutics, IncBought (not open market)—

Companies traded

  • ATTO Attovia Therapeutics, Inc: other filings, last Aug 4, 2026
  • RCUS Arcus Biosciences, Inc: other filings, last Jan 16, 2019
  • MYOK MyoKardia Inc: other filings, last Jan 18, 2017

Get free alerts when Steven Chan files a new trade →